Guilfoyle Brian J MD - Coventry, Rhode Island 02816

Guilfoyle Brian J MD is categorized under Doctors in Coventry, RI .

Business Name: Guilfoyle Brian J MD
Contact Person: Brian Guilfoyle
Address: 300 Goldfinch Drive, Coventry, Rhode Island 02816
Phone Number: (401) 822-0389
Annual Revenue (USD): $100.000 to $499.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:
Related Businesses: Okosun Edoro Md Mph - Coventry, RI 02816
Larlham Suzanne MD - Coventry, RI 02816
Roberts Diane MD - Coventry, RI 02816
Wortman Bethany MD - Coventry, RI 02816
Hershey Steven PhD - Coventry, RI 02816
Buck Sarah MD - Coventry, RI 02816
Grande Karen MD - Coventry, RI 02816
Hebb Donald B MD - Coventry, RI 02816
Mayo Lori MD - Coventry, RI 02816
Berchard Elizabeth MD - Coventry, RI 02816
Pezzullo Steven R MD - Coventry, RI 02816
Powers Marilyn M MD - Coventry, RI 02816
Famador MA L MD - Coventry, RI 02816
Golomb Duane T MD - Coventry, RI 02816
Manown Timothy J MD - Coventry, RI 02816
Goccia Richard J MD - Coventry, RI 02816
Collins Daniel F MD - Coventry, RI 02816
Moretti Jill MD - Coventry, RI 02816
Lukatela Katarina PhD - Coventry, RI 02816
Fulton Paul DO - Coventry, RI 02816

The company Guilfoyle Brian J MD provides B2C services in the form of Doctors from its single location in Rhode Island. 1 to 4 employees work for Guilfoyle Brian J MD, and the business now earns $100.000 to $499.999 per annum.

Guilfoyle Brian J MD was launched in 0 and is classified under SIC code and category 8011 , and NAICS number and grouping 6211110 . To contact Guilfoyle Brian J MD, please call Brian Guilfoyle with the phone number (401) 822-0389 or visit its single location at 300 Goldfinch Drive in Coventry, Rhode Island 02816.

The location of the single location can also be found using the coordinates 41.673613,-71.592855. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.